Amring Pharms Company Profile

What is the competitive landscape for AMRING PHARMS, and what generic alternatives to AMRING PHARMS drugs are available?

AMRING PHARMS has fourteen approved drugs.

There are eight US patents protecting AMRING PHARMS drugs.

There are eight patent family members on AMRING PHARMS drugs in two countries and thirty-one supplementary protection certificates in ten countries.

Summary for Amring Pharms

International Patents:	8
US Patents:	8
Tradenames:	13
Ingredients:	13
NDAs:	14

Drugs and US Patents for Amring Pharms

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Amring Pharms	SUCCINYLCHOLINE CHLORIDE	succinylcholine chloride	INJECTABLE;INJECTION	210231-001	Jun 4, 2018	AP	RX	No	No
Amring Pharms	NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN	gramicidin; neomycin sulfate; polymyxin b sulfate	SOLUTION/DROPS;OPHTHALMIC	065187-001	Oct 28, 2005	AT	RX	No	No
Amring Pharms	ISOPROTERENOL HYDROCHLORIDE	isoproterenol hydrochloride	INJECTABLE;INJECTION	211237-001	May 19, 2021	AP	RX	No	No
Amring Pharms	LYSTEDA	tranexamic acid	TABLET;ORAL	022430-001	Nov 13, 2009	AB	RX	Yes	Yes	9,060,939		Y
Amring Pharms	TIMOLOL MALEATE	timolol maleate	SOLUTION/DROPS;OPHTHALMIC	212592-001	Dec 13, 2021	AT3	RX	No	No
Amring Pharms	NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE	hydrocortisone; neomycin sulfate; polymyxin b sulfate	SOLUTION/DROPS;OTIC	065216-001	Oct 31, 2005		DISCN	No	No

Paragraph IV (Patent) Challenges for AMRING PHARMS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Tablets	650 mg		2011-05-24

International Patents for Amring Pharms Drugs

Country	Patent Number	Estimated Expiration
Japan	2011168596
World Intellectual Property Organization (WIPO)	2006023000
Japan	2008508276
World Intellectual Property Organization (WIPO)	2006023001
Japan	2014193878
Japan	2008508275

Supplementary Protection Certificates for Amring Pharms Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
3461484	SPC/GB21/033	United Kingdom		PRODUCT NAME: A COMBINATION OF LATANOPROST AND NETARSUDIL; REGISTERED: UK EU/1/20/1502(FOR NI) 20210107; UK PLGB 16053/0034 20210107
0364417	97C0128	France		PRODUCT NAME: LATANOPROST; REGISTRATION NO/DATE IN FRANCE: NL 22549 DU 19970724; REGISTRATION NO/DATE AT EEC: 12716 DU 19960718
0364417	61/1997	Austria		PRODUCT NAME: LATANOPROST UND SEINE THERAPEUTISCH AKTIVEN UND PHYSIOLOGISCH ANNEHMBAREN DERIVATE; NAT. REGISTRATION NO/DATE: 1-22019 19970627; FIRST REGISTRATION: SE 12716 19960718
3461484	C202130024	Spain		PRODUCT NAME: NETARSUDIL O UN ENANTIOMERO, DIASTEREIOISOMERO, SAL O SALVADO DEL MISMO EN COMBINACION CON LATANOPROST O UNA SAL DEL MISMO; NATIONAL AUTHORISATION NUMBER: EU/1/20/1502; DATE OF AUTHORISATION: 20210107; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/20/1502; DATE OF FIRST AUTHORISATION IN EEA: 20210107
0364417	SPC/GB97/014	United Kingdom		PRODUCT NAME: LATANOPROST (I.E. 13,14-DIHYDRO-17-PHENYL-18,19,20-TRINOR-PGF-ALPHA-ISOPROPYLESTER); NAT. REGISTRATION NO/DATE: 00032/0220 19961216; FIRST REGISTRATION: SE 12716 19960718; SPC EXTENSION AUTHORISATION: PL00057/1057-008 20101216
3461484	301101	Netherlands		PRODUCT NAME: LATANOPROST OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN EN NETARSUDILMESYLAAT; REGISTRATION NO/DATE: EU/1/20/1502 20210108

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Amring Pharms